Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05486884

Mean Arterial Pressure After Out-of-hospital Cardiac Arrest

Mean Arterial Pressure After Out-of-hospital Cardiac Arrest: the METAPHORE Randomized Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,380 (estimated)
Sponsor
Centre Hospitalier le Mans · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Out-of-hospital cardiac arrest is a public health problem for which overall survival is below 10%. Post-cardiac arrest syndrome is the principal cause of death in intensive care units (ICU), due to refractory shock or brain injuries secondary to anoxia. Brain anoxia is responsible for severe neurological sequelae that may be aggravated by cerebral hypoperfusion during the first few hours after the return of spontaneous circulation. Current recommendations are to ensure that arterial blood pressure is sufficient for the perfusion of organs, but no minimum threshold mean arterial pressure (MAP) has been defined. In practice, most teams target a MAP of at least 65 mmHg. Several observational studies have shown a correlation between MAP and neurological prognosis, patients with a higher initial MAP having a better outcome. Recent pilot studies have demonstrated the feasibility of increasing the target MAP after cardiac arrest, but conflicting results have been obtained concerning patient prognosis. These findings may be explained by changes to the autoregulation of the brain after cardiac arrest, with a shift of the curve towards the right, or its abolition. Cerebral blood flow is dependent on MAP, and a target MAP of 65 mmHg for these patients may result in insufficient brain perfusion. Conversely, a too high MAP might cause brain lesions due to vasogenic edema, hemorrhagic complications or excess perfusion in conditions of diminished brain metabolism. An interventional study is required to evaluate the effect of increasing MAP on neurofunctional outcome after cardiac arrest. Given the data available for brain autoregulation, the correlation between MAP and prognosis, and the risks theoretically associated with a higher MAP, investigator plans to compare a standard threshold of MAP (≥ 65 mmHg) with a high threshold of MAP (≥ 90 mmHg). Investigator hypothesizes that a high MAP within the first 24 hours after cardiac arrest will improve neurofunctional outcome.

Conditions

Interventions

TypeNameDescription
PROCEDUREMaintain MAP ≥ 90 mmHgMaintain MAP ≥ 90 mmHg for the 24 hours following inclusion by perfusion of norepinephrine
PROCEDUREMaintain MAP ≥ 65 mmHgMaintain MAP ≥ 65 mmHg for 24 hours after randomization through the perfusion of norepinephrine

Timeline

Start date
2024-09-28
Primary completion
2028-03-28
Completion
2028-03-28
First posted
2022-08-04
Last updated
2025-03-26

Locations

27 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05486884. Inclusion in this directory is not an endorsement.